Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens (GlobeNewswire, Akers Biosciences Inc.) - Apr 8, 2020 - "Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc (the "Company") (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its collaboration with Premas Biotech has successfully completed a second milestone, the successful expression of the three coronavirus antigens, Spike (S), Envelope (E), and Membrane (M), that were selected for their vaccine candidate."
Clinical • Commercial • New trial
|